Medical Advisory Board
Our goal is to provide the most up-to-date, extensive, and accurate medical information available related to FAVA. Members of Project FAVA's Medical Advisory Board provide advice and guidance to our organization as we fulfill this goal.
All medical information on this website has been developed with oversight from members of Project FAVA's Medical Advisory Board.
Denise Adams, MD
Denise Adams, MD is an academic Pediatric Hematologist-Oncologist. She is currently a Co-Director of the Vascular Anomalies Center at Boston Children's Hospital and is an Associate Professor of Pediatrics at Harvard Medical School. Immediately prior to that, she was the Medical Director of the Hemangioma and Vascular Malformation Center and Director of the Pediatric Hematology/Oncology Fellowship Program at Cincinnati Children's Hospital Medical Center. Dr. Adams is actively involved in clinical and translational research in the field of vascular anomalies, including exploration of various medical therapies for the treatment of FAVA and other vascular anomalies. She has received several awards for her instruction and mentorship of medical students, residents, and fellow physicians. In addition, she has authored many publications and has been an invited speaker, both nationally and internationally, on the subject of vascular anomalies.
Elizabeth Chao, MD, FACMG
Elizabeth Chao, MD, FACMG is a clinical and molecular geneticist. She is the Director of Molecular Genetics and an Assistant Professor of Genetics and Genomics in Pediatrics at the University of California, Irvine. Dr. Chao served previously as Chief Medical Officer at Ambry Genetics, where she led the development and launch of the first commercially available whole exome sequencing test for rare pediatric diseases in 2011. She has authored numerous publications, including on clinical genomics, whole exome sequencing, and DNA variant classification. Dr. Chao is experienced in the development and implementation of genomic testing to manage rare pediatric diseases. Her research focuses on novel methodologies for the interpretation of genomic variation and the translation of DNA sequence information into improvements in clinical care.